Fluoxetine trial in suicidal depressed alcoholics

J. R. Cornelius, Ihsan M Salloum, M. D. Cornelius, J. M. Perel, M. E. Thase, J. G. Ehler, J. J. Mann

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The selective serotonergic agonist fluoxetine has demonstrated efficacy in the treatment of depression and has suggested efficacy in the treatment of alcoholism. However, no trials with any selective serotonin agonist have been reported in patients who display both major depression and alcoholism. In this study, 12 patients with DSM-III-R diagnoses of major depressive disorder and alcohol dependence were treated openly with fluoxetine for 8 weeks, with doses ranging from 20 mg to 40 mg p.o. qAM. All 12 patients reported prominent suicidal ideation upon admission to our hospital; 6 had made serious suicide attempts shortly before admission. Statistically significant improvements were noted on measures of depression and postdischarge alcohol consumption. No paradoxical increases in suicidality were noted. These findings suggest that fluoxetine has potential for treating the depressive symptoms and the excessive alcohol intake of depressed alcoholics.

Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalPsychopharmacology Bulletin
Volume29
Issue number2
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Fluoxetine
Alcoholics
Depression
Alcoholism
Serotonin Receptor Agonists
Suicidal Ideation
Major Depressive Disorder
Diagnostic and Statistical Manual of Mental Disorders
Alcohol Drinking
Suicide
Alcohols

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology

Cite this

Cornelius, J. R., Salloum, I. M., Cornelius, M. D., Perel, J. M., Thase, M. E., Ehler, J. G., & Mann, J. J. (1993). Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin, 29(2), 195-199.

Fluoxetine trial in suicidal depressed alcoholics. / Cornelius, J. R.; Salloum, Ihsan M; Cornelius, M. D.; Perel, J. M.; Thase, M. E.; Ehler, J. G.; Mann, J. J.

In: Psychopharmacology Bulletin, Vol. 29, No. 2, 01.01.1993, p. 195-199.

Research output: Contribution to journalArticle

Cornelius, JR, Salloum, IM, Cornelius, MD, Perel, JM, Thase, ME, Ehler, JG & Mann, JJ 1993, 'Fluoxetine trial in suicidal depressed alcoholics', Psychopharmacology Bulletin, vol. 29, no. 2, pp. 195-199.
Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG et al. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin. 1993 Jan 1;29(2):195-199.
Cornelius, J. R. ; Salloum, Ihsan M ; Cornelius, M. D. ; Perel, J. M. ; Thase, M. E. ; Ehler, J. G. ; Mann, J. J. / Fluoxetine trial in suicidal depressed alcoholics. In: Psychopharmacology Bulletin. 1993 ; Vol. 29, No. 2. pp. 195-199.
@article{cd08dd73e55340f9b9c3416123556f3d,
title = "Fluoxetine trial in suicidal depressed alcoholics",
abstract = "The selective serotonergic agonist fluoxetine has demonstrated efficacy in the treatment of depression and has suggested efficacy in the treatment of alcoholism. However, no trials with any selective serotonin agonist have been reported in patients who display both major depression and alcoholism. In this study, 12 patients with DSM-III-R diagnoses of major depressive disorder and alcohol dependence were treated openly with fluoxetine for 8 weeks, with doses ranging from 20 mg to 40 mg p.o. qAM. All 12 patients reported prominent suicidal ideation upon admission to our hospital; 6 had made serious suicide attempts shortly before admission. Statistically significant improvements were noted on measures of depression and postdischarge alcohol consumption. No paradoxical increases in suicidality were noted. These findings suggest that fluoxetine has potential for treating the depressive symptoms and the excessive alcohol intake of depressed alcoholics.",
author = "Cornelius, {J. R.} and Salloum, {Ihsan M} and Cornelius, {M. D.} and Perel, {J. M.} and Thase, {M. E.} and Ehler, {J. G.} and Mann, {J. J.}",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "29",
pages = "195--199",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "2",

}

TY - JOUR

T1 - Fluoxetine trial in suicidal depressed alcoholics

AU - Cornelius, J. R.

AU - Salloum, Ihsan M

AU - Cornelius, M. D.

AU - Perel, J. M.

AU - Thase, M. E.

AU - Ehler, J. G.

AU - Mann, J. J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The selective serotonergic agonist fluoxetine has demonstrated efficacy in the treatment of depression and has suggested efficacy in the treatment of alcoholism. However, no trials with any selective serotonin agonist have been reported in patients who display both major depression and alcoholism. In this study, 12 patients with DSM-III-R diagnoses of major depressive disorder and alcohol dependence were treated openly with fluoxetine for 8 weeks, with doses ranging from 20 mg to 40 mg p.o. qAM. All 12 patients reported prominent suicidal ideation upon admission to our hospital; 6 had made serious suicide attempts shortly before admission. Statistically significant improvements were noted on measures of depression and postdischarge alcohol consumption. No paradoxical increases in suicidality were noted. These findings suggest that fluoxetine has potential for treating the depressive symptoms and the excessive alcohol intake of depressed alcoholics.

AB - The selective serotonergic agonist fluoxetine has demonstrated efficacy in the treatment of depression and has suggested efficacy in the treatment of alcoholism. However, no trials with any selective serotonin agonist have been reported in patients who display both major depression and alcoholism. In this study, 12 patients with DSM-III-R diagnoses of major depressive disorder and alcohol dependence were treated openly with fluoxetine for 8 weeks, with doses ranging from 20 mg to 40 mg p.o. qAM. All 12 patients reported prominent suicidal ideation upon admission to our hospital; 6 had made serious suicide attempts shortly before admission. Statistically significant improvements were noted on measures of depression and postdischarge alcohol consumption. No paradoxical increases in suicidality were noted. These findings suggest that fluoxetine has potential for treating the depressive symptoms and the excessive alcohol intake of depressed alcoholics.

UR - http://www.scopus.com/inward/record.url?scp=0027521904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027521904&partnerID=8YFLogxK

M3 - Article

C2 - 8290665

AN - SCOPUS:0027521904

VL - 29

SP - 195

EP - 199

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 2

ER -